March 29, 2024
Inflation Progress Stalls, Fed’s Preferred Gauge shows the core PCE index rose 2.8% in February from a year earlier, matching the January year-over-year change.
Subscription is coming; a “buck” a day will keep your portfolio in play - be a subscriber to continue reading! Join me … in the NO spin zone and new website!
Never leave an investor uninformed!
March 29, 2024
A scorecard of earnings releases of covered companies -
The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status".
29 of 35 covered released to date
March 29, 2024
March and Q1/24 end tomorrow, Friday a market holiday with inflation numbers released at 8:30 a.m., ET
The Harvard Apparatus RT (OTCQB: HRGN) formerly Biostage (BSTG) Chronicles: Question, Is it a Ponzi Scheme? <see The Bottom Line> Also, where are the Q4 and FY23 earnings reporting - hiding?
Subscription is coming; a “buck” a day will keep your portfolio in play - be a subscriber to continue reading! A 360-degree review of the who, why, when and what happened in the sector as the market and economics surround your portfolio defense.
Never leave an investor uninformed! A trusted source of factual reporting!
The week in Review
March 29, 2024
A scorecard of earnings releases of covered companies - The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status". 29 of 35 covered released to date
March 22, 2024
SGMO dived $0.1465 to $08238 or -15.098% And pre-funded warrants of 3,809,523 shares of common stock, together with accompanying warrants to purchase up to an aggregate of 28,571,428 shares of common stock priced at $0.83 Gross proceeds $24 M possible Barclays and Cantor are acting as placement agents for the offering
March 19, 2024
FATE opened +$0.10 to $7.14 In addition, Fate priced a concurrent private placement of pre-funded warrants to purchase 3,636,364 shares of its common stock at a purchase price of $5.499 per pre-funded warrant, to certain institutional and other accredited investors affiliated with or managed by Redmile Group, LLC. The offering includes participation from new and existing institutional investors: Adage Capital Partners LP., Boxer Capital, Deep Track Capital, OrbiMed, Suvretta Capital and a life-sciences focused investor.
1 hour 24 min ago
RegMed Investors’ (RMi) pre-open: Personal Consumption Expenditures price index (PCE) rose
2 hours 26 min ago
RegMed Investors (RMi) - Q4/23 & FY23 Cell and Gene Therapy Earnings Scorecard Results
2 hours 27 min ago
RegMed Investors (RMi) Closing Bell: done and over, portfolios escaped bloodied but, relatedly intact